Thomas DM - Search Results

1

Liposarcoma: molecular genetics and therapeutics.

Conyers R, Young S, Thomas DM. Conyers R, et al. Among authors: thomas dm. Sarcoma. 2011;2011:483154. doi: 10.1155/2011/483154. Epub 2010 Dec 27. Sarcoma. 2011. PMID: 21253554 Free PMC article.

2

Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.

Ito M, Barys L, O'Reilly T, Young S, Gorbatcheva B, Monahan J, Zumstein-Mecker S, Choong PF, Dickinson I, Crowe P, Hemmings C, Desai J, Thomas DM, Lisztwan J. Ito M, et al. Among authors: thomas dm. Clin Cancer Res. 2011 Feb 1;17(3):416-26. doi: 10.1158/1078-0432.CCR-10-2050. Epub 2010 Dec 15. Clin Cancer Res. 2011. PMID: 21159888

3

Targeting the p53 Pathway in Ewing Sarcoma.

Neilsen PM, Pishas KI, Callen DF, Thomas DM. Neilsen PM, et al. Among authors: thomas dm. Sarcoma. 2011;2011:746939. doi: 10.1155/2011/746939. Epub 2010 Dec 9. Sarcoma. 2011. PMID: 21197471 Free PMC article.

4

Hereditary and environmental epidemiology of sarcomas.

Thomas DM, Savage SA, Bond GL. Thomas DM, et al. Clin Sarcoma Res. 2012 Oct 4;2(1):13. doi: 10.1186/2045-3329-2-13. Clin Sarcoma Res. 2012. PMID: 23036137 Free PMC article. No abstract available.

5

Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells.

Cain JE, McCaw A, Jayasekara WS, Rossello FJ, Marini KD, Irving AT, Kansara M, Thomas DM, Ashley DM, Watkins DN. Cain JE, et al. Among authors: thomas dm. Sarcoma. 2013;2013:608964. doi: 10.1155/2013/608964. Epub 2013 Feb 28. Sarcoma. 2013. PMID: 23533324 Free PMC article.

6

Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.

Collins M, Wilhelm M, Conyers R, Herschtal A, Whelan J, Bielack S, Kager L, Kühne T, Sydes M, Gelderblom H, Ferrari S, Picci P, Smeland S, Eriksson M, Petrilli AS, Bleyer A, Thomas DM. Collins M, et al. Among authors: thomas dm. J Clin Oncol. 2013 Jun 20;31(18):2303-12. doi: 10.1200/JCO.2012.43.8598. Epub 2013 May 13. J Clin Oncol. 2013. PMID: 23669227

7

Specific targets in sarcoma and developmental therapeutics.

Thomas DM, Wagner AJ. Thomas DM, et al. J Natl Compr Canc Netw. 2010 Jun;8(6):677-85; quiz 686. doi: 10.6004/jnccn.2010.0050. J Natl Compr Canc Netw. 2010. PMID: 20581299

8

Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours.

Kelleher FC, Thomas DM. Kelleher FC, et al. Among authors: thomas dm. Clin Sarcoma Res. 2012 Feb 1;2(1):6. doi: 10.1186/2045-3329-2-6. Clin Sarcoma Res. 2012. PMID: 22587874 Free PMC article.

9

The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic research.

Young MA, Herlihy A, Mitchell G, Thomas DM, Ballinger M, Tucker K, Lewis CR, Neuhaus S; International Sarcoma Kindred Study; Halliday J. Young MA, et al. Among authors: thomas dm. Clin Sarcoma Res. 2013 Jul 30;3(1):11. doi: 10.1186/2045-3329-3-11. Clin Sarcoma Res. 2013. PMID: 23898988 Free PMC article.

10

Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review.

Lewin J, Wieringa S, Collins M, Desai J, Orme L, Lingaratnam S, Thomas DM. Lewin J, et al. Among authors: thomas dm. Clin Sarcoma Res. 2013 Dec 10;3(1):15. doi: 10.1186/2045-3329-3-15. Clin Sarcoma Res. 2013. PMID: 24321600 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

527 results

Search Page